Mark McLaws

Dr. Mark McLaws joined Asymchem in May 2015. As Vice President, Dr. McLaws heads a team of technical experts to support CMC activities with a particular focus on late-stage development, validation, and commercialization. Dr. McLaws obtained a Ph.D. from the University of Utah. Dr. McLaws has over 17 years of process chemistry experience in the pharmaceutical manufacturing industry. During his career, he has supported the process development and manufacturing of clinical phase and commercial small molecule APIs in a variety of therapeutic areas.